BioCentury
ARTICLE | Clinical News

Ablynx preclinical data

January 19, 2009 8:00 AM UTC

In a mouse model of viral infection, intratracheal Antiviral Nanobodies neutralized the undisclosed viral target for at least 72 hours. The Nanobodies had 5 to 10 times greater bioavailability when de...